Biphasic Production of Anti-ApoB100 Autoantibodies in Obese Humans and Mice.

Autor: Choe MK; Department of Molecular & Life Science, College of Science & Technology, Hanyang University (ERICA), 55 Hanyangdaehak-ro, Sangnok-gu, Ansan, Gyeonggi-do 15588, Korea., Kim HJ; Asan Medical Center, Department of Neurology, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 05505, Korea., Kim NH; Department of Internal Medicine, Division of Endocrinology and Metabolism, College of Medicine, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 02841, Korea., Binas B; Department of Molecular & Life Science, College of Science & Technology, Hanyang University (ERICA), 55 Hanyangdaehak-ro, Sangnok-gu, Ansan, Gyeonggi-do 15588, Korea., Kim HJ; Department of Molecular & Life Science, College of Science & Technology, Hanyang University (ERICA), 55 Hanyangdaehak-ro, Sangnok-gu, Ansan, Gyeonggi-do 15588, Korea.
Jazyk: angličtina
Zdroj: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2021 Apr 04; Vol. 14 (4). Date of Electronic Publication: 2021 Apr 04.
DOI: 10.3390/ph14040330
Abstrakt: Obesity is associated with autoimmunity, a phenomenon considered as harmful. Here we show that obese mice and humans produce IgG-type autoantibodies that specifically recognize apolipoprotein B-100 (ApoB100), its native epitope p210, and the synthetic p210 mimotope pB1. By contrast, antibodies against epitopes p45 and p240, which have been associated with atherosclerosis, were not detected in either the humans or mice. In a longitudinal analysis of high fat diet-fed mice, autoantibody production rose with increasing body weight, then decreased and plateaued at morbid obesity. Likewise, in a cross-sectional analysis of sera from 148 human volunteers spanning a wide BMI range and free of comorbidities, the immunoreactivity increased and then decreased with increasing BMI. Thus, the obesity-related ApoB100-specific natural autoantibodies characteristically showed the same epitope recognition, IgG-type, and biphasic serum levels in humans and mice. We previously reported that a pB1-based vaccine induces similar antibodies and can prevent obesity in mice. Therefore, our present results suggest that autoantibodies directed against native ApoB100 may mitigate obesity, and that the vaccination approach may be effective in humans.
Databáze: MEDLINE
Nepřihlášeným uživatelům se plný text nezobrazuje